United States· US:68547-578_4a9a731f-e065-420a-b480-c592c4228b04
ZEVTERA
A medicinal product containing ceftobiprole medocaril sodium, registered in United States by La Jolla Pharmaceutical Company.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEFTOBIPROLE MEDOCARIL SODIUM
- Manufacturer
- La Jolla Pharmaceutical Company
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1168547-578-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftobiprole medocaril sodium in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMabelio 500 mgBasilea Medical
- GermanyZevteraAdvanz Pharma Limited
- FinlandZevteraBasilea Pharmaceutica Deutschland GmbH
- FranceMABELIO 500 mg, poudre pour solution à diluer pour solution pour perfusionADVANZ PHARMA LIMITED
- IrelandAdaluzis 500mg Powder for concentrate for solution for infusionAdvanz Pharma Limited
- NorwayZevteraBasilea Pharmaceutica Deutschland GmbH
- SwedenZevtera 500 mg Pulver till koncentrat till infusionsvätska, lösningBasilea Pharmaceutica Deutschland GmbH
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Zevtera
- Germany · Zevtera
- Denmark · Zevtera
- Spain · Zevtera
- Finland · Zevtera
- France · Mabelio
- United Kingdom (Northern Ireland) · Zevtera
- Ireland · Adaluzis
- Italy · Mabelio
- Luxembourg · Mabelio, Zevtera
- Norway · Zevtera
- Poland · Zevtera
- Portugal · Zevtera
- Sweden · Zevtera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3d351d6c-0938-4049-b2af-ee9c63e7e3f9 GET /v1/drugs/3d351d6c-0938-4049-b2af-ee9c63e7e3f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "667",
"substance": "CEFTOBIPROLE MEDOCARIL SODIUM",
"productndc": "68547-578",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA218275",
"marketing_category": "NDA"
}See everything about ceftobiprole medocaril sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.